The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
Recommendations for chamber quantification☆
LANG, R., BIERIG, M., DEVEREUX, R., FLACHSKAMPF, F., FOSTER, E., PELLIKKA, P., PICARD, M., ROMAN, M., SEWARD, J., & SHANEWISE, J. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.12.014 · Cited by 3,571
Tei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., Tajik, A. J., & Seward, J. B. (1995) · PubMed · Cited by 1,547
Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview
Ignarro, L. J., Cirino, G., Casini, A., & Napoli, C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00016 · Cited by 763
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Self-citationLevine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
Cardiotoxicity of cytotoxic drugs
Schimmel, K. J. M., Richel, D. J., van den Brink, R. B. A., & Guchelaar, H.-J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.003 · Cited by 391
Rationale and design: PRiSM Psychosis Study 1
Thornicroft, G., Strathdee, G., Phelan, M., Holloway, F., Wykes, T., Dunn, G., McCrone, P., Leese, M., Johnson, S., & Szmukler, G. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.5.363 · Cited by 319
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
Zhou, S., Starkov, A. A., Froberg, M. K., Leino, R. L., & Wallace, K. B. (2001) · PubMed · Cited by 314
Adriamycin cardiomyopathy: pathophysiology and prevention
Singal, P. K., Iliskovic, N., Li, T., & Kumar, D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337145 · Cited by 310
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
Ryberg, M., Nielsen, D., Skovsgaard, T., Hansen, J., Jensen, B. V., & Dombernowsky, P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3502 · Cited by 289
Cardiomyocyte apoptosis and progression of heart failure to transplantation
Saraste, Pulkki, Kallajoki, Heikkilä, Laine, Mattila, Nieminen, Parvinen, & Voipio‐Pulkki (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00481.x · Cited by 211
Münzel, T., & Gori, T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.066 · Cited by 203
Mason, R. P., Kalinowski, L., Jacob, R. F., Jacoby, A. M., & Malinski, T. (2005) · Circulation · doi:10.1161/circulationaha.105.556233 · Cited by 194
Cardiotoxicity of the Antiproliferative Compound Fluorouracil
Becker, K., Erckenbrecht, J. F., aussinger, D. H., & Frieling, T. (1999) · Drugs · doi:10.2165/00003495-199957040-00003 · Cited by 172
Review: 5-Fluorouracil cardiotoxicity: A critical review
Gradishar, W., & Vokes, E. E. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057793 · Cited by 117
Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.
Iqbal, M., Dubey, K., Anwer, T., Ashish, A., & Pillai, K. K. (2008) · PubMed · Cited by 115
The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy
Bien, S., Riad, A., Ritter, C. A., Gratz, M., Olshausen, F., Westermann, D., Grube, M., Krieg, T., Ciecholewski, S., Felix, S. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1344 · Cited by 111
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
Matsui, H., Morishima, I., Numaguchi, Y., Toki, Y., Okumura, K., & Hayakawa, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00362-8 · Cited by 103
Tocchetti, C. G., Ragone, G., Coppola, C., Rea, D., Piscopo, G., Scala, S., Lorenzo, C. D., Iaffaioli, R. V., Arra, C., & Maurea, N. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr165 · Cited by 88
Antioxidant Activity of Nebivolol in the Rat Aorta
de Groot, A. A., Mathy, M. J., van Zwieten, P. A., & Peters, S. L. M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200401000-00022 · Cited by 80
Chao, H.-H., Liu, J., Hong, H.-J., Lin, J., Chen, C., & Cheng, T. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.06.010 · Cited by 68
Shibata, M. C., Flather, M. D., Böhm, M., Borbola, J., Solal, A. C., Dumitrascu, D., Ferrari, R., Lechat, P. P., Parkhomenko, A. N., Soler‐Soler, J., et al. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00321-2 · Cited by 65
de Nigris, F., Rienzo, M., Schiano, C., Fiorito, C., Casamassimi, A., & Claudio Napoli, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.010 · Cited by 62
Chemoprotectants for cancer chemotherapy.
Dorr, R. T. (1991) · PubMed · Cited by 53
Preventive Cardioprotection of Erythropoietin Against Doxorubicin-induced Cardiomyopathy
Chen, X., Chen, Y., Bi, Y.-Y., Fu, N., Shan, C., Wang, S., Aslam, S., Peixian, W., & Xu, J. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6052-0 · Cited by 50
Zhang, J., Herman, E., & Ferrans, V. J. (1993) · PubMed · Cited by 44
CO and bilirubin inhibit doxorubicin-induced cardiac cell death
Kim, D., Chae, S., Kim, H., & Chae, H. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802354762 · Cited by 27
5-fluorouracil cardiotoxicity: A unique mechanism for ischaemic cardiopathy and cardiac failure?
Lieutaud, T., Brain, E. G. C., Goldgran-Tolédano, D., Vincent, F., Cvitkovic, E., Leclercq, B., & Escudier, B. J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00575-7 · Cited by 24
Liu, T. C. K., Ismail, S., Brennan, O., Hastings, C. L., & Duffy, G. P. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.523 · Cited by 19
Cited by
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Anthracycline Chemotherapy and Cardiotoxicity
McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6711-0 · Cited by 956
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Metadata
- Authors
- Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., Berk, V., Ardic, I., Ergin, A., & Lam, Y. Y.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 167
- Issue
- 5
- Pages
- 2306-2310
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2094415834
- Cited by
- 325
- References
- 31
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.